Third SARS-CoV-2 vaccination and breakthrough infections enhance humoral and cellular immunity against variants of concern

INTRODUCTION: SARS-CoV-2 vaccination is the leading strategy to prevent severe courses after SARS-CoV-2 infection. In our study, we analyzed humoral and cellular immune responses in detail to three consecutive homologous or heterologous SARS-CoV-2 vaccinations and breakthrough infections. METHODS: P...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruhl, Louisa, Kühne, Jenny F., Beushausen, Kerstin, Keil, Jana, Christoph, Stella, Sauer, Jasper, Falk, Christine S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073596/
https://www.ncbi.nlm.nih.gov/pubmed/37033958
http://dx.doi.org/10.3389/fimmu.2023.1120010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073596/
https://www.ncbi.nlm.nih.gov/pubmed/37033958
http://dx.doi.org/10.3389/fimmu.2023.1120010

Ejemplares similares